Sinus Dilation Devices Market to Witness Growth at a Substantial CAGR of 9.14% Reaching USD 2.35 Billion by 2026, Estimates DelveInsight

LAS VEGAS, Feb. 15, 2022 /PRNewswire/ -- Sinus Dilation Devices Market is anticipated to experience rising demand in the coming years due to several factors such as the rising burden of sinusitis across the globe, recent product launches and approvals, as well as the presence of many key Sinus Dilation Devices market players such as Johnson & Johnson, Stryker, Dalent Medical, and many more.

DelveInsight's Sinus Dilation Devices Market Insights and Forecast report provides the current and forecast Sinus Dilation Devices Market, upcoming innovation in the devices, individual market shares, challenges, drivers and barriers, market trends, and key competitors in the Sinus Dilation Devices Market. 

Some of the salient features from the Sinus Dilation Devices Market report: 

• As per DelveInsight analysis, in terms of revenue share, North America is predicted to register the fastest growth in the Sinus Dilation Devices market.
• Key players working proactively in the Sinus Dilation Devices Market include Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., Smith & Nephew, Medtronic, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Jilin Coronado Medical Apparatus Co., Ltd., Leno Medical Technology (Shanghai) Co., Ltd., SPIGGLE & THEIS Medizintechnik GmbH, InnAccel, Surgical Holdings., SinuPulse, Sklar Surgical Instruments, XION, Entermed, Optim LLC, KARL STORZ, Wolf GmbH, and others.
• DelveInsight analyzes that Global Sinus Dilation Devices Market was valued at USD 1.40 billion in 2020, and is expected to grow at a substantial CAGR of 9.14% during the forecast period from 2021 to 2026. Sinus Dilation Devices market size is anticipated to reach USD 2.35 billion by 2026.
• In July 2021, Intersect ENT, Inc. commercially launched its VenSure balloon sinus dilation devices in the U.S.
• In September 2020, Intersect ENT, Inc. entered into an agreement to acquire Fiagon AG Medical Technologies. The combination of both the company's portfolio allows delivering more comprehensive surgical solutions across the sinusitis care continuum.
• In August 2020, Acclarent Inc. received FDA clearance for its Next Generation Balloon Dilation System, an integrated balloon sinuplasty (BSP) and Eustachian tube (ET) dilation device intended to provide a means to access the sinus space within and across nasal and sinus structures.

To pick on the latest highlights related to Sinus Dilation Devices, get the snapshot of the key highlights entailed in the Sinus Dilation Devices Market Report

Sinus Dilation Devices Overview 

Sinus Dilation Devices are medical devices used for broadening the sinus openings during sinus surgery to treat sinus drainage problems. Sinus Dilation Devices comprise endoscopes (sinuscope and rhinoscope) for visualization during surgery along with a sinus balloon dilation system, sinus implants, and others.

Sinus Dilation Devices Market Insight 

Among all the regions, North America is expected to occupy a major share in the overall Sinus Dilation Devices market during the forthcoming years. This domination is owing to the increasing prevalence of the target population in the region. Moreover, the presence of a well-established reimbursement policy, recent product approvals in the region, and presence of key Sinus Dilation Devices market players active such as Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., among others are also expected to augment the Sinus Dilation Devices market. 

For instance, on May 20, 2021, Intersect ENT, a global ear, nose, and throat ("ENT") medical technology company received a CE mark for its PROPEL® Contour (mometasone furoate) sinus implant (specifically designed for inflammation reduction by providing mechanical support and steroid delivery). Furthermore, the Asia-pacific region has future potential for the Sinus Dilation Devices market. 

Click here to understand more about the Sinus Dilation Devices Market Landscape @ Sinus Dilation Devices Market Assessment

Sinus Dilation Devices Market Dynamics 

The major factors driving the demand for Sinus Dilation Devices are the rising burden of sinusitis across the globe, recent product approvals and launches, as well as the presence of several reimbursement policies and initiatives concerned with the treatment of sinusitis are all responsible for the Sinus Dilation Devices market growth. 

The rise in demand for Sinus Dilation Devices is attributed to the growing incidence of rhinosinusitis both acute and chronic among the worldwide population. Moreover, the rising preference for the minimally invasive procedures and benefit of balloon sinuplasty over conventional treatment methods is also expected to surge the Sinus Dilation Devices market. Also, increasing technological advancement and the presence of key Sinus Dilation Devices market players are other aspects responsible for global Sinus Dilation Devices market growth.

However, on the other hand, the sudden outbreak of COVID-19 led to a backlog of surgical procedures and interruption in routine patient care followed by suspension of routine surgeries during the crisis. Also, many health organizations have canceled routine clinical visits to curb the transmission of the virus. Moreover, few health organizations have shifted their focus towards managing the deadly virus infection which led to delayed surgery in rhinology, particularly with regards to chronic rhinosinusitis which affected the Sinus Dilation Devices market a lot. The availability of alternative treatment regimens and lack of skilled otolaryngologists and ENT surgeons are also some of the factors likely to impede the Sinus Dilation Devices market.

To gain a better understanding of the COVID-19 impact on Sinus Dilation Devices, get a snapshot of the Sinus Dilation Devices Market Analysis

Scope of the Sinus Dilation Devices Market Report

• Coverage: Global
• Study Period: 2021-2026
• Market Segmentation By Product Type - Balloon Sinuplasty Devices, Sinus Implants/Stents, Functional Endoscopic Sinus Surgery Instruments Set, And Others
• Market Segmentation By End-User- Hospitals, ENT Clinics, Ambulatory Surgical Centers, And Others
• Market Segmentation By Geography - North America, Europe, Asia-Pacific, and Rest of World
• Key Sinus Dilation Devices Companies -  Johnson & Johnson, Stryker, Dalent Medical, Intersect ENT, Inc., Smith & Nephew, Medtronic, Meril Life Sciences Pvt. Ltd., Olympus Corporation, Jilin Coronado Medical Apparatus Co., Ltd., Leno Medical Technology (Shanghai) Co., Ltd., SPIGGLE & THEIS Medizintechnik GmbH, InnAccel, Surgical Holdings., SinuPulse, Sklar Surgical Instruments, XION, Entermed, Optim LLC, KARL STORZ, Wolf GmbH, and others.
• Porter's Five Forces Analysis
• Product Profiles
• Case Studies 
• KOL's Views
• Analyst's View

Delveinsight Analysis: The Global Sinus Dilation Devices market is expected to grow at a compound annual growth rate (CAGR) of 9.14% during the forecast period and will reach USD 2.35 billion by 2026.

Know more about which MedTech player is set to emerge as the trendsetter @ Sinus Dilation Devices Market Landscape Analysis 

Table of Contents 

Learn more about the report offerings @ Sinus Dilation Devices Market Outlook

Related Reports

Sinuscope Market

"DelveInsight's 'Sinuscope - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Sinuscope and the historical and forecasted Sinuscope market trends, market drivers, market barriers and major players involved like AMD Global Telemedicine, GAES, Olympus America, asap endoscopic products, XION GmbH, LocaMed, Optim, MedServ, KARL STORZ, Entermed, Henke-Sass, Wolf GmbH, Easmed, Beijing Hamamatsu, Basda, and others.

Paranasal Sinus Cancer Pipeline

DelveInsight's, "Paranasal Sinus Cancer – Pipeline Insight, 2022," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in the Paranasal Sinus Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key companies involved such as Exelixis, Bristol-Myers Squibb, Eli Lily, S.L.A. Pharma AG, Celgene, and others.

Airway Management Devices Market

Global Airway Management Devices Market was valued at USD 1.51 billion in 2020, growing at a CAGR of 6.20% during the forecast period from 2021 to 2026, to reach USD 2.35 billion by 2026. The report delivers an in-depth understanding of the Airway Management Devices, historical and forecasted epidemiology as well as key companies involved in pipelines such as Smiths Medical PLC, Narang Medical Limited, Intersurgical Ltd, Teleflex Incorporated, Stryker Corporation, Medtronic PLC, and others.

Asthma Diagnostic Devices Market

"DelveInsight's 'Asthma Diagnostic Devices Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Asthma Diagnostic Devices and the historical and forecasted Asthma Diagnostic Devices market trends, drivers, barriers and key companies involved such as Medline Industries, Becton, Dickinson and Company, Siemens Process Instrumentation, Smiths Medical, Vyaire Medical, Nihon Kohden Corporation, Vitalograph, Circassia Limited, Intermedical (UK) Limited, and several others.

Pulse Oximeters Market

DelveInsight's 'Pulse Oximeters - Market Insights, Competitive Landscape and Market Forecast - 2026' report delivers an in-depth understanding of Pulse Oximeters, historical and forecasted Pulse Oximeters market trends, market drivers, market barriers and key companies involved like Medtronic, Nonin Medical Inc, Lepu Medical Technology, TytoCare Ltd, VYAIRE, OMRON Corporation. Meditech Equipment Co ., Ltd, and several others.

Cough Assist Devices Market

"DelveInsight's 'Cough Assist Devices - Market Insight, Competitive Landscape and Market Forecast, 2026' report delivers an in-depth understanding of Cough Assist Devices and the historical and forecasted Cough Assist Devices market trends, market drivers & barriers, unmet needs and key companies involved such as Koninklijke Philips N.V, Percussionaire Corp., Emerson, Hill Rom, Dima Italia SRL, and many more.

Interstitial Lung Diseases Pipeline

DelveInsight's, "Interstitial Lung Diseases - Pipeline Insight, 2021," report provides comprehensive insights about 100+ companies and 100+ pipeline drugs in the Interstitial Lung Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and non-clinical stage products and key companies involved like AdAlta, Bristol-Myers Squibb, aTyr Pharma, Avalyn Pharmaceuticals, Beijing Continent Pharmaceutical, Regend Therapeutics, Reata Pharmaceuticals, FibroGen, PureTech Health, Bellerophon Pulse Technologies, OncoArendi Therapeutics, LTT Bio-Pharma, EmphyCorp, Genentech, Blade Therapeutics, Acceleron Pharma and many more.

Artificial Lung Devices Pipeline

DelveInsight's, "Artificial Lung Devices–Pipeline Insight and Competitive Landscape, 2021," report provides comprehensive insights about 20+ companies and 23+ pipeline devices in the artificial lung devices pipeline landscape which includes key companies like Lung Biotechnology, Miromatrix, Charles Stark Draper Laboratory Inc, United Therapeutics Corporation, XVIVO Perfusion, Medtronic, Getinge, Xenios AG, ALung Technologies Inc., MC3 Cardiopulmonary, Abiomed and many more.

Interested to know more about the breakthrough happenings? Take a look at the posts below 

• Sinusitis: Something More Troublesome Than Just Cold
• Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs
• Migraine Market: How Pharma Companies are trying to Uncomplicate the Disease and Bring in Novel Therapies

About DelveInsight

DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.  Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect With Us at LinkedIn | Facebook | Twitter

Contact Us

Shruti Thakur 
[email protected] 
+1(919)321-6187 
www.delveinsight.com

SOURCE DelveInsight Business Research, LLP